A detailed history of Friess Associates LLC transactions in Electromed, Inc. stock. As of the latest transaction made, Friess Associates LLC holds 50,614 shares of ELMD stock, worth $1.45 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
50,614
Previous 66,214 23.56%
Holding current value
$1.45 Million
Previous $824,000 40.78%
% of portfolio
0.81%
Previous 0.44%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$9.58 - $12.85 $149,448 - $200,460
-15,600 Reduced 23.56%
50,614 $488,000
Q1 2022

May 12, 2022

BUY
$11.5 - $13.23 $32,936 - $37,890
2,864 Added 4.52%
66,214 $824,000
Q4 2021

Feb 11, 2022

BUY
$10.71 - $13.0 $678,478 - $823,550
63,350 New
63,350 $824,000
Q2 2020

Aug 14, 2020

SELL
$10.27 - $17.28 $1.46 Million - $2.45 Million
-142,000 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$7.0 - $12.93 $994,000 - $1.84 Million
142,000 New
142,000 $1.6 Million

Others Institutions Holding ELMD

About Electromed, Inc.


  • Ticker ELMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,492,200
  • Market Cap $244M
  • Description
  • Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consist...
More about ELMD
Track This Portfolio

Track Friess Associates LLC Portfolio

Follow Friess Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Friess Associates LLC with notifications on news.